Kayentis Chooses SFR Business Team for its "Machine to Machine" Roaming in Close to 250 Countries
Grenoble, 1st Septembre 2015 – Kayentis, French software provider specialized in solutions for clinical pharmaceutical trials, has just chosen SFR Business Team for its M2M roaming in close to 250 countries.
Kayentis has been a leading name in solutions for clinical trials for 10 years. 18 months ago, in addition to its emblematic digital pen device, the company launched a solution enabling patient data to be entered by tablet.
In order to implement its solutions in the international market, Kayentis wished to approach a major player in the telecoms sector and thus chose SFR Business Team. The partnership agreement between the two companies authorises M2M roaming in close to 250 countries.
This solution guarantees permanent connectivity between the clinic investigation centres, where the data is collected, the Kayentis database servers and the portal provided for its customers.
It has already been implemented in more than 40 countries, via two eCOA projects (eClinical Outcome Assessment) for phase III clinical studies, linked with one of the five largest pharmaceutical laboratories in the world.
Working with SFR Business Team has enabled Kayentis to lean on one of the leading names in MtoM solutions worldwide and strengthen the brand’s ambitious plans for development.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
